Individual patient meta-analysis supports tPA stroke benefits

The benefits of intravenous tissue plasminogen activator outweigh the risks in acute stroke patients treated within 4.5 hours of symptom onset, reports the Stroke Thrombolysis Trialists’ Collaboration.

Source: MedWire News - June 11, 2016 Category: Consumer Health News Tags: Stroke Source Type: news